Table 2. Types of long-acting injectable antipsychotic (LAI) used by serious mental illness (SMI) patients in the Assertive Community Treatment (ACT) program.

Type of LAI used	Proportion hospitalizations using Long acting injectable
Paliperidone	25 (14.0%)
Aripiprazole (Abilify Maintena)	16 (8.9%)
Aripiprazole lauroxil (Aristada)	3 (1.7%)
Risperidone	31 (17.3%)
Fluphenazine (Prolixin)	7 (3.9%)
Haloperidol (Haldol) decanoate	22 (12.3%)